Copyright ©2007 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

MICHELE NORRIS, host:

From NPR News, this is ALL THINGS CONSIDERED. I'm Michele Norris.

MELISSA BLOCK, host:

And I'm Melissa Block.

There is the first of sorts to tell you about today in Major League Baseball. Jason Giambi of the New York Yankees has agreed to meet with former Senator George Mitchell who's heading up baseball's steroids investigation.

In a statement, Giambi said commissioner Bud Selig impressed upon him the idea that the game of baseball would be best served by such a meeting. Selig described Giambi's cooperation as an important step forward.

NORRIS: Until today, Mitchell has been having trouble finding willing participants for his inquiry. He doesn't have the power to issue subpoenas. And it took threats of disciplinary action, even a suspension from the commissioner to get Giambi to talk. But there will be ground rules.

Giambi will have to speak about his own experience with performance-enhancing drugs, but he won't implicate other players.

Copyright © 2007 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.